Proof of Concept Trial or “POC Trial” means the Phase I human proof of concept trial in patients for a GT Product as set forth in, and conducted pursuant to, the Research Plan.
Proof of Concept Trial or "POC TRIAL" shall mean an initial phase II clinical trial of a Development Candidate [ * ].
Proof of Concept Trial or “PoC Trial” shall mean (a) with respect to a CCR9 Development Candidate, the PROTECT-1 Trial, and (b) with respect to any other Development Candidate, the first Phase 2 Clinical Trial of such Development Candidate that is reasonably designed to satisfy the PoC Criteria and demonstrate efficacy, with statistical significance within a [***] that is no longer than [***] in a [***] Indication approved by the JSC pursuant to Section 2.3.5. For clarity, the Proof of Concept Trial is intended only to demonstrate the efficacy of a particular Development Candidate, and is not intended to be a pivotal trial or dose-ranging study, or intended to otherwise provide data sufficient to support Regulatory Approvals. In the event that any single PoC Trial would exceed either (i) a total of [***] and/or (ii) a total cost of [***] Dollars ($[***]), the provisions of Section 2.3.6 shall apply.
Examples of Proof of Concept Trial in a sentence
Ezutromid Clinical DevelopmentEzutromid: Phase 2 Proof of Concept Trial PhaseOut DMD is a 48-week, open-label Phase 2 clinical trial evaluating ezutromid in patients with DMD.
The appropria- tion revenue comprises a cash component and a receivable (asset).
A Proof of Concept Trial of an mHeath Program for Smoking Cessation and Anxiety Sensitivity Reduction Among Black Adults Who Smoke.
A Proof of Concept Trial of an Online Psychoeducational Program for Relatives of Both Veterans and Civilians Living with Schizophrenia.
P&G shall pay Regeneron *** million promptly upon *** after its *** the Proof of Concept Trial results.
More Definitions of Proof of Concept Trial
Proof of Concept Trial or “POC Trial” shall mean with respect to any Research Program Development Candidate, NP201 Development Candidate or Tail Compound, as applicable, the first human clinical trial that either: (i) is reasonably designed to; and/or (ii) actually does, establish POC in humans. For clarity, the concept of a “Proof of Concept Trial” is intended only to identify the time point at which the POC of a particular Research Program Development Candidate, NP201 Development Candidate or Tail Compound has been demonstrated, and a “Proof of Concept Trial” is not [*]
Proof of Concept Trial means a human clinical trial (however denominated) that is conducted in order to ascertain the efficacy of a product and that precedes a Phase II Clinical Trial.
Proof of Concept Trial means any Phase IIA Clinical Trial or Phase IIB Clinical Trial that is designed to demonstrate that a Collaboration Product meets clinical criteria established by the JDC with respect to a given indication.
Proof of Concept Trial or “PoC Trial” shall mean, with respect to any Development Candidate, the first Phase 2 Clinical Trial of such Development Candidate that is reasonably designed, subject to Section 2.3.4(b), to satisfy the PoC Criteria if successful. For clarity, the Proof of Concept Trial is intended only to provide evidence of the efficacy of a particular Development Candidate and is not intended to be a pivotal trial or dose-ranging study or otherwise to provide data sufficient to support any Regulatory Approval.
Proof of Concept Trial means the first clinical trial in humans that is conducted for the purpose of determining the safety and efficacy of AXOKINE for weight reduction and glucose control in Type II diabetics (or as otherwise modified by the OC) and that the OC specifically designates as such.
Proof of Concept Trial means a Clinical Trial of Licensed Product in patients that demonstrates efficacy on an efficacy endpoint and therefore justifies proceeding with pivitol Phase III Clinical Trials or other pivitol registration Clinical Trials required for Final Regulatory Approval of Licensed Product.
Proof of Concept Trial has the meaning ascribed to it in Section 3.3(a) of this Agreement.